Bryan Johnson, a longevity researcher, shares his profound experience with 5-MeO-DMT, the most powerful psychedelic, and discusses its effects on consciousness, brain function, and potential longevity benefits. He also explores the risks, therapeutic potential, and future of psychedelics alongside other cutting-edge longevity therapies like mitochondrial and gene therapy.
Bryan Johnson, a well-known figure in longevity research, recently took 5-MeO-DMT, described as the most powerful psychedelic on the planet, and shared his experience and insights. This article delves into his journey, the science behind psychedelics and longevity, and the broader implications for health and human potential.
5-MeO-DMT is a psychedelic compound that is estimated to be 5 to 10 times more powerful than DMT. Unlike DMT, which is highly visual, 5-MeO-DMT induces a profound experience of raw consciousness and intelligence with very little visual effects.
Johnson's primary motivation was to explore its potential as a longevity experiment. Over the past five years, he has systematically studied scientific evidence on health and longevity, focusing on interventions with the best evidence and effect size. Psychedelics were not initially on his radar as a rejuvenation protocol but more as treatments for depression and anxiety.
However, preclinical evidence in mice suggested psilocybin might have longevity benefits. Johnson conducted a quantified experiment with psilocybin and found promising results, which led him to explore 5-MeO-DMT.
Johnson describes the experience as:
He explains the critical moment during the experience where one must completely relinquish ego, control, and attachment to enter a state of unimaginable bliss and euphoria. This experience was the most dynamic he has ever had, surpassing major life events.
The internal monologue of the ego turns off, leaving a visceral hyper-awareness of existence.
5-MeO-DMT and psilocybin both affect the brain's default mode network (DMN), which constructs self and ego. The DMN is responsible for rumination and self-referential thoughts. Psychedelics dampen or dissolve the DMN, allowing for new neural connections and increased neuroplasticity.
Johnson's brain imaging studies with Kernel showed that psilocybin reorganizes brain connectivity, creating new patterns and quieting old ones. This rewiring can help trauma victims by breaking repetitive negative thought patterns.
Johnson found that psilocybin induced a metabolic reset in his brain, significantly improving blood glucose levels and altering his microbiome. This suggested potential longevity benefits through reduced inflammation and rejuvenated brain function.
He hypothesizes that 5-MeO-DMT may have similar or even more profound effects, as it completely annihilated his DMN compared to psilocybin's dampening effect.
Post-experience, Johnson noticed:
He acknowledges the profound psychological rejuvenation equivalent to decades of mental reset.
Psychedelics carry risks, including the potential to induce permanent psychoses in predisposed individuals and the possibility of traumatic "bad trips." Johnson emphasizes the importance of:
He notes that many negative outcomes arise from unsupervised, recreational use without knowledge of dosage or strain.
Johnson reflects on the philosophical questions psychedelics raise about identity and self, given the profound rewiring of the brain they induce. He also considers the rapid pace of societal and technological change, suggesting psychedelics might help humans adapt more quickly by enhancing psychological flexibility.
He contrasts the typical adult narrowing of ambition and openness with the youthful, expansive mindset psychedelics can restore.
Beyond psychedelics, Johnson is exploring:
These therapies aim to complement lifestyle interventions like exercise, nutrition, and sleep.
Johnson sees psychedelics as uniquely powerful for psychological rejuvenation, complementing physical therapies. While mitochondrial and gene therapies may restore bodily functions, psychedelics may restore a youthful disposition and mental flexibility.
Bryan Johnson's experience with 5-MeO-DMT highlights the profound potential of psychedelics as part of a broader longevity and health optimization strategy. While promising, these substances require careful, supervised use due to their power and risks. Alongside emerging biotechnologies, psychedelics may play a crucial role in extending not just lifespan but healthspan and psychological vitality.
Johnson remains optimistic about the future of longevity science and the integration of novel therapies to enhance human life.
This comprehensive exploration offers valuable insights into the intersection of psychedelics, neuroscience, and longevity, inviting further research and thoughtful consideration of these powerful tools.
